Osteoarthritis (OA) Clinical Trial
Official title:
Effect of Sit 'N' Fit Chair Yoga on Community-Dwelling Elders With Osteoarthritis
Verified date | August 2019 |
Source | Florida Atlantic University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The current study is a two-arm randomized controlled clinical trial to test the feasibility of recruiting, randomizing, and having older adults with osteoarthritis (OA) adhere to and safely complete the 8-week Sit 'N' Fit Chair Yoga program and the HEP program (primary objective). Secondary objectives of the study were to determine the effect of the Sit 'N' Fit Chair Yoga Program to reduce levels of pain; improve physical function, psychosocial function, and life satisfaction in adults over 65 years of age who were unable to participate in standing exercise. Participants at two sites were randomly assigned to either the intervention group (Sit 'N' Fit Chair Yoga) or attention control group (Health Education Program). Data collectors were blinded to group assignments. Data were collected prior to the intervention (baseline), after 4 weeks, and after 8 weeks. Follow-up data were collected after 1 month and after 3 months after completion of the intervention to measure the extent to which effects of the intervention continue. Evaluations were include physical measures and self-report measures.
Status | Completed |
Enrollment | 131 |
Est. completion date | September 2016 |
Est. primary completion date | June 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility |
Inclusion Criteria: 1. age 65 years or older 2. living independently in the community and noninstitutionalized at the time of the study 3. self-reported joint pain verified by Dr. McCaffrey and a Project Director (nurse practitioner) to be caused by OA and present in one or more lower extremity joints (hip, knee, foot, or ankle) 4. ability to ambulate independently with or without assistive devices 5. chronic pain at least 15 days of the month for 3 months or longer at a level of at least 4 (moderate pain) on a 0-10 pain bothersomeness scale (0 = no pain to 10 = excruciating pain) 6. self-reported inability to participate in regular yoga or standing exercise due to physical disability, fatigue, fear of falling, or balance problems 7. not currently participating in yoga or any other exercise program 8. ability to understand English or Spanish 9. ability to come to designated site at the scheduled times 10. willingness to be audiotaped during the intervention sessions Exclusion Criteria: 1. Knee surgery (or knee-arthroscopy) or hip(s) within 12 weeks prior to enrollment, causing pain or functional problems 2. Systemic or intra-articular corticosteroid use within 60 days of the screening visit 3. Serious comorbidity that makes it impossible to participate in the yoga intervention (e.g., heart failure-New York Heart Association (NYHA IV) 4. Require assistance by another person (e.g., holding the arm or walking behind) in order to ambulate 30 feet 5. Participation in yoga or exercise program currently or in the previous 3 months, or planning to participate in yoga or other exercise program during the chair yoga intervention (including 3-month follow-up) 6. Intra-articular steroid injections within 4 weeks of screening 7. Inability to understand or speak English or Spanish 8. Inability to correctly answer questions, complete the demographic data form, and continue with yoga practice for 1 month post intervention. This is measured by asking participants the following questions (Alzheimer's Association's "questions to determine early cognitive impairment) (http://www.alz.org/alzheimers_disease_10_signs_of_alzheimers.asp) as accessed August 27, 2013, as approved by our geriatric content expert, Dr. Joseph Ouslander). Those who answer three or more of these questions incorrectly are excluded from the study. 1. What is today's date? 2. What day of the week is today? 3. On what street do you live? 4. In what town do you live? 5. In what state is your town? 6. Who is the President? 7. What season of the year is this? 8. What month are we in now? 9. How did you get here today? Screening Evaluation All participants must have OA. As diagnostic criteria for OA, the participant must exhibit at least three of the following upon history or physical examination to be considered to have a diagnosis of OA and thus to be eligible to participate in the study: - Pain in the affected joint - Morning stiffness that is relieved as the day progresses - Crepitus on active motion - Bony tenderness - Bony enlargement - Decreased range of motion of joint - Joint instability upon standing or bending - Increased pain and fatigue with walking or standing - The participant must ambulate at least 30 feet without assistance from another person (may use cane, walker, or wheelchair). Those who require personal assistance to ambu-late 30 feet (such as needing to hold an arm or to have someone walk behind for safety) are excluded because they would not be able to complete the 6-Minute Walk or Gait Speed Test. During the screening of potential participants each person is asked whether he or she is able to participate in standing exercise programs or regular yoga programs. The following questions are asked and people are eligible if they identify any two of the following: Please check any of the following that you feel unable to do because of balance, pain, fear of falling, fatigue or strength - Standing for 30-45 minutes - Bending over toward your toes - Bending side to side - Squatting - Standing on one foot - Standing, holding your arms outstretched above your head - Twisting your body side to side |
Country | Name | City | State |
---|---|---|---|
United States | North East Focal Point Senior Center | Deerfield Beach | Florida |
United States | Douglas Gardens North (Public Housing Facility) | Pembroke Pines | Florida |
Lead Sponsor | Collaborator |
---|---|
Florida Atlantic University | National Center for Complementary and Integrative Health (NCCIH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | PROMIS Pain Interference | The 8-item PROMIS Pain Inference-Short Form- V. 1.0-8a was administered to measure self-reported consequences of pain on various aspects of the participant's life.Scores can range from 8 (minimum) to 40 (maximum) and higher scores indicate more interference with daily activities. This tool is normed on the U.S. general population, with an average score of 50 and a standard deviation of 10, to report interference within the previous 7 days on 5-point response scale ranging from not at all to very much. This self-report measure was developed by the NIH. NIH has rigorously tested the construct validity and reliability of all of the PROMIS tools and all have been shown to be internally consistent, reliable (reliability = .96 to .99, for PROMIS-PI SF) and valid (construct validity). A higher score represent a severe pain level. | 6 months | |
Primary | Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) | The Western Ontario and McMaster Universities Osteoarthritis Index was administered to measure self-reported. The tool, recommended for osteoarthritis clinical trials, is a self-administered scale with 24 questions using a Likert-type scale. The Western Ontario and McMaster Universities Osteoarthritis Index was administered to measure self-reported OA symptoms (pain, stiffness, functional ability). The tool is a self-administered scale with 24 items (pain [5 items], stiffness [2 items], physical function [17 items]). A score range for each subscale for each scale (minimum-maximum) is Pain 0-20, stiffness 0-8, physical function 0-68. Higher scores indicate worse pain, stiffness, and functional limitations. For this study, we used a subscale of pain (5 items), stiffness (2 items), physical function (17 items). A total score of all subscales can range from 0 (minimum) to 96 (maximum). The WOMAC demonstrated a Cronbach's alpha of .95 for persons with OA. | 6 months | |
Secondary | PROMIS Physical Function | The PROMIS Physical Function Short Form-V 1.0-12a was administered to measure physical function. The domain of physical function assesses self-reported ability rather than actual performance of physical activities. Scores can range from 7 (minimum) to 60 (maximum). The higher scores represent better physical function.This includes functioning of upper extremities (dexterity), lower extremities (mobility), and central regions (neck back), as well as instrumental activities of daily living. Each question has five response options, ranging in value from 1 (unable to do) to 5 (able to do without any difficulty). | 6 months | |
Secondary | Gait Speed Test | The Gait Speed Test was used to measure physical function. Gait speed measurement is considered highly reliable in older adults without known impairments that should affect gait. For measuring gait speed, the unit of measurement is the second. Intrarater reliability (N = 19-24) and test-retest reliability (N = 19-41) have been reported as high (ICC = .90-.96, r = 89-100). The Pearson correlation coefficient is r = .93 and ICC = .78 for test-retest reliability for gait speed in older adults. | 6 months | |
Secondary | Berg Balance Scale | The Berg Balance Scale was administered to measure changes in balance function. The performance-based Berg Balance Scale contains 14 items applying a 5-point scale for each item (0 = lowest level of function to 4 = highest level of function); scores range from 0 to 56. Higher scores indicate higher fall risk. The Berg Balance Scale is the gold standard assessment of balance, obtaining good to excellent intra-rater reliability (ICC = 0.68-0.99) and interrater reliability (ICC = 0.88-0.98) and good internal validity. | 6 months | |
Secondary | 6-Minute Walk Test | The 6-Minute Walk Test was administered to measure changes in exercise tolerance in participants. The tool measured the distance(yards) a participant walked in 6 minutes on a hard and flat surface. Less distances (yards) covered in 6 minutes indicate lower function. | 6 months | |
Secondary | PROMIS Emotional Distress-Depression (Short Form) | The PROMIS Emotional Distress and Depression-V 1.0-Short Form-8a was administered o measure depressive symptoms. The tool has a 5-point scale for each item (1 = Never to 5 = Always); scores can range from 8 to 40. Higher scores indicate higher levels of depression and emotional distress. | 6 months | |
Secondary | PROMIS Fatigue Scale | The PROMIS Fatigue scale was administered to evaluate a range of self-reported symptoms, from mild subjective feelings of tiredness to an overwhelming, debilitating, and sustained sense of exhaustion that decreases ability to execute daily activities and to function normally in family or social roles.It ranges 8-40 and higher scores indicate higher level of fatigue. | 6 months | |
Secondary | PROMIS Ability to Participate in Social Activities | The PROMIS Ability to Participate in Social Activities-V 2.0- SF-8a was administered to measure the perceived ability to perform usual social roles and activities. Items are worded negatively in terms of perceived limitations (5 = Never to 1 = Always), but responses are reverse-coded .Scores can range from 8 to 40; higher scores indicate lower ability to participate in social roles. | 6 months | |
Secondary | Life Satisfaction Index-Short Form (LSITA-SF) | The Life Satisfaction Index-Short Form was administered to measure general life satisfaction in participants. The 12-item index offers a 6-point scale for each item (1 = strongly agree to 6 = strongly disagree; for Items 2, 4, 5, and 6, the responses are reversed. It ranges 12 (minimum)-72 (maximum); higher scores indicate higher level of life satisfaction. Reliability of this instrument when used with 654 older adults produced a Cronbach's alpha of .95, with a goodness of fit of > .90. It has a correlated reliability of .90 with the long form. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01620541 -
Comparing Ankle Fusion to Ankle Replacement
|
||
Completed |
NCT01577563 -
Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).
|
N/A | |
Terminated |
NCT04941729 -
Study to Evaluate the Safety and Efficacy of OR3O™ Dual Mobility System vs. Conventional Single Bearing Design Total Hip System
|
N/A | |
Active, not recruiting |
NCT04097379 -
Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA
|
Phase 2 | |
Completed |
NCT02726945 -
Adipose-derived SVF for the Treatment of Knee OA
|
N/A |